AFArmelle Forrer

Armelle Forrer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Armelle Forrer has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Healthcare associated infections and associated antimicrobial resistance in four African countries

    by Armelle Forrer, Henry Kajumbula, Edward O. Nyarko, Immaculate Barasa, Moses Odhiambo, Argwings Chagwira, Kennedy Abangi, Royce Abisai, Noel Lozani, Jonathan Ngoma, et al.

    Background Healthcare-associated infections (HAIs) significantly contribute to patient morbidity and mortality worldwide, particularly in sub-Saharan Africa (sSA), where prevalence rates range between 6.7% and 28%. HAI are particularly associated with extensive antimicrobial resistance (AMR), which may potentially render HAI untreatable in settings with poor access to Watch and Reserve antibiotics. Methods This observational cohort study, conducted across hospitals in Kenya, Ghana, Malawi, and Uganda, aimed to estimate antimicrobial resistance (AMR) rates in HAIs, describe clinical outcomes, and assess hospital length of stay (LoS) among hospitalized patients with HAIs. Kaplan Meir plots were used to explore the impact of treatment adequacy on survival rate for different HAIs. Mixed-effect logistic regression models were used to assess the impact of drug resistance or treatment inadequacy on odds of survival. Results Of 336 participants enrolled between October 2021 and January 2023, 207 had at least one positive microbiological test, contributing 244 isolates. The highest AMR prevalence was observed in the Enterobacterales family, Staphylococcus aureus , and Acinetobacter spp. of which 85.3% (116/136), 78.6% (11/14) and 72.7% (16/22) exhibited AMR, respectively. Over 80.9% (114/141) of pathogenic isolates were either 3GC-R or MDR and 88.6% of those (101/114) were both MDR and 3GC-R. There was a 16.7% case fatality rate, with inadequate or unknown adequacy of antimicrobial treatment significantly associated with increased odds of death in patients with bloodstream infection, hospital acquired pneumonia or complicated skin and soft tissue infection (OR 2.90, 95% CI 0.99–8.36). Increased odds of death were also associated with hospital stay in an ICU ward (OR 4.70, 95%CI 1.80–12.32) and with increasing years of age (OR 1.01, 95%CI 1.01–1.04). Conclusion The findings highlight the urgent need for local treatment guidelines, improved infection prevention and control measures, and antimicrobial stewardship in sSA to reduce the burden of AMR and improve patient outcomes.

  • Open Access

    The impact of the termination of Lymphatic Filariasis mass drug administration on Soil-transmitted Helminth prevalence in school children in Malawi

    by Faduma Farah, Claudio Fronterrè, Mark J. Taylor, Armelle Forrer

    Background: Soil-transmitted helminths (STH) have been passively targeted through the implementation of mass drug administration (MDA), with the drugs ivermectin and albendazole, against the parasitic disease, lymphatic filariasis (LF). In Malawi, LF MDA was administered to communities between 2008 and 2014. The aim of this analysis was to estimate the impact of LF MDA and its termination on STH prevalence in school aged children (SAC). Methodology: School survey data of STH prevalence in Malawi were obtained through the ESPEN website. The surveys spanned the periods before (1998–2004), during (2012–2014) and after LF MDA (2015–2019). Bayesian mixed-effects models were fitted to estimate the impact of LF MDA termination, and other STH risk factors, on the odds of infection, as well as generate predictions of nationwide STH prevalence during and after LF MDA. Principal findings: SAC after the termination of LF MDA had 1.8 times greater odds of A. lumbricoides infection compared to SAC during the implementation of LF MDA (95% credible interval (CI): 1.03 – 3.35), despite ongoing STH preventive chemotherapy (PC) targeting SAC. Predictions indicate majority of districts increased in their probability of exceeding 2% A. lumbricoides prevalence in SAC after the termination of LF MDA, with Chitipa, Mulanje and Nsanje districts estimated to have > 80% probability of exceeding 2% prevalence. Conclusions/significance: An overall resurgence in A. lumbricoides infections after LF MDA was estimated in SAC, despite ongoing annual STH PC. This suggests STH PC could not sustain the prevalence levels achieved in SAC under community-wide LF MDA. The potential role of drug resistance in this resurgence calls for urgent investigation. Understanding how this resurgence corresponds to prevalence of moderate and heavy infections should be a priority for future research.

  • Open Access

    The impact of the termination of Lymphatic Filariasis mass drug administration on Soil-transmitted Helminth prevalence in school children in Malawi

    by Faduma Farah, Claudio Fronterre, Mark J Taylor, Armelle Forrer

    Background: Soil-transmitted helminths (STH) have been passively treated with the implementation of mass drug administration (MDA), with the drugs ivermectin and albendazole, against the parasitic disease, lymphatic filariasis (LF). In Malawi, LF MDA was administered to communities between 2008 and 2014. The aim of this analysis is to estimate the impact of LF MDA and its termination on STH prevalence in school aged children. Methodology: School survey data of STH prevalence in Malawi were obtained through the ESPEN website. The surveys spanned the periods before (1998-2004), during (2012-2014) and after LF MDA (2015-2019). Bayesian mixed-effects models were fit to estimate the impact of LF MDA termination, and other STH risk factors, on the odds of infection as well as generate predictions of nationwide STH prevalence after LF MDA. Principal findings: School children after the termination of LF MDA had a threefold increase in the odds of A. lumbricoides infection compared to school children during the implementation of LF MDA (Odds Ratio (OR): 3.4, 95% credible interval (CI): 1.99 – 5.94), despite ongoing STH preventive chemotherapy targeting school age children. In contrast, school children had lower odds of hookworm infection after LF MDA compared to during (OR: 0.5, 95% CI: 0.33 – 0.73). Mulanje district in the south has above 50% probability of exceeding 20% A. lumbricoides prevalence while the probability for exceeding 20% hookworm prevalence is below 50% nationwide. Conclusions/significance: An overall resurgence in A. lumbricoides infections after LF MDA is identified in school children despite ongoing annual STH preventive chemotherapy. Monitoring of STH prevalence and infection intensity using high sensitivity diagnostics should be prioritised to surveil this resurgence and better delineate infection hotspots. A greater assessment of underlying factors would also further aid the identification of hotspots. Author Summary: Soil-transmitted helminths (STH) are a group of parasitic worms that cause infections. They cause significant morbidity in children and women and the World Health Organisation (WHO) recommends the mass distribution of drugs to these populations to treat infections. In Malawi, distribution of albendazole to school age children to treat STH has been conducted annually since at least 2012. In the past, Malawi also distributed albendazole to whole communities to treat another parasitic disease, lymphatic filariasis (LF). The aim of this study was to investigate the impact of terminating LF treatment on STH prevalence in school children. We found that after mass LF treatment was stopped, school children had around three times the odds of infection for one species of STH, compared to school children during the time of LF treatment distribution. This indicates a resurgence in infection, despite ongoing STH treatment, after community-wide treatment against LF was stopped. To better understand the lack of community treatment and its impact, monitoring of STH prevalence and infection intensity with more sensitive diagnostics needs to be prioritised to avoid further resurgence of infection. An understanding of underlying factors, such as population movement or the potential emergence of drug resistance, would also help in identifying hotspots.

  • Open Access

    Multimethod evaluation of health services integration for neglected tropical diseases requiring case management in Liberia

    by Karsor K. Kollie, Sally Theobald, Lent Jones, Otis Kpadeh, Gartee Nallo, Darwosu Borbor, Mark Taylor, Laura Dean, Maneesh Phillip, Tiawanlyn G Godwin-Akpan, et al.

    Introduction The WHO neglected tropical disease (NTD) roadmap stresses the importance of integrating NTDs requiring case management (CM) within the health system. The NTDs programme of Liberia is among the first to implement an integrated approach and evaluate its impact. Methods A retrospective study of three of five CM-NTD-endemic counties that implemented the integrated approach was compared with cluster-matched counties with non-integrated CM-NTD. We compared trends in CM-NTD integrated versus non-integrated county clusters. We conducted a pre-post comparison of WHO high-level outcomes using data collected during intervention years compared with baseline in control counties. Changes in health outcomes, effect sizes for different diseases and rate ratios with statistically significant differences were determined. Complementary qualitative research explored CM-NTD stakeholders’ perceptions, analysed through the framework approach, which is a transparent, multistage approach for qualitative thematic interdisciplinary data analysis. Results The detection rates for all diseases combined improved significantly in the intervention compared with the control clusters. Besides leprosy, detection rates improved with large effects, over fourfold increase with statistically significant effects for individual diseases (pConclusions Integrating CM-NTDs improves case detection, accessibility and availability of CM-NTD services, promoting universal health coverage. Early case detection and the quality of care need further strengthening.


  • Open Access

    Infrared Thermal Imaging as a Novel Non-Invasive Point-of-Care Tool to Assess Filarial Lymphoedema

    by Louise A. Kelly-Hope, Mohammad Jahirul Karim, Asm Sultan Mahmood, Abdullah Al Kawsar, Abul Khair, Hannah Betts, Janet Douglass, Armelle Forrer, Mark J. Taylor

    Lymphatic filariasis causes disfiguring and disabling lymphoedema, which is commonly and frequently exacerbated by acute dermatolymphangioadenitis (ADLA). Affected people require long-term care and monitoring but health workers lack objective assessment tools. We examine the use of an infrared thermal imaging camera as a novel non-invasive point-of-care tool for filarial lower-limb lymphoedema in 153 affected adults from a highly endemic area of Bangladesh. Temperature differences by lymphoedema stage (mild, moderate, severe) and ADLA history were visualised and quantified using descriptive statistics and regression models. Temperatures were found to increase by severity and captured subclinical differences between no lymphoedema and mild lymphoedema, and differences between moderate and severe stages. Toes and ankle temperatures detected significant differences between all stages other than between mild and moderate stages. Significantly higher temperatures, best captured by heel and calf measures, were found in participants with a history of ADLA, compared to participants who never had ADLA, regardless of the lymphoedema stage. This novel tool has great potential to be used by health workers to detect subclinical cases, predict progression of disease and ADLA status, and monitor pathological tissue changes and stage severity following enhanced care packages or other interventions in people affected by lymphoedema.


  • Open Access

    Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol

    by Samuel Wanji, Theobald Mue Nji, Louise Hamill, Laura Dean, Kim Ozano, Abdel J. Njouendou, Raphael A. Abong, Elisabeth Dibando Obie, Andrew Amuam, Relindis Ekanya, et al.

    Background: Onchocerciasis is a priority neglected tropical disease targeted for elimination by 2025. The standard strategy to combat onchocerciasis is annual Community-Directed Treatment with ivermectin (CDTi). Yet, high prevalence rates and transmission persist following > 12 rounds in South-West Cameroon. Challenges include programme coverage, adherence to, and acceptability of ivermectin in an area ofLoa loaco-endemicity. Loiasis patients harbouring heavy infections are at risk of potentially fatal serious adverse events following CDTi. Alternative strategies are therefore needed to achieve onchocerciasis elimination where CDTi effectiveness is suboptimal.Methods/design: We designed an implementation study to evaluate integrating World Health Organisation-endorsed alternative strategies for the elimination of onchocerciasis, namely test-and-treat with the macrofilaricide, doxycycline (TTd), and ground larviciding for suppression of blackfly vectors with the organophosphate temephos. A community-based controlled before-after intervention study will be conducted among > 2000 participants in 20 intervention (Meme River Basin) and 10 control (Indian River Basin) communities. The primary outcome measure isO. volvulusprevalence at follow-up 18-months post-treatment. The study involves four inter-disciplinary components: parasitology, entomology, applied social sciences and health economics. Onchocerciasis skin infection will be diagnosed by skin biopsy andLoa loainfection will be diagnosed by parasitological examination of finger-prick blood samples. A simultaneous clinical skin disease assessment will be made. Eligible skin-snip-positive individuals will be offered directly-observed treatment for 5 weeks with 100 mg/day doxycycline. Transmission assessments of onchocerciasis in the communities will be collected post-human landing catch of the local biting blackfly vector prior to ground larviciding with temephos every week (0.3 l/m3) until biting rate falls below 5/person/day. Qualitative research, including in-depth interviews and focus-group discussions will be used to assess acceptability and feasibility of the implemented alternative strategies among intervention recipients and providers. Health economics will assess the cost-effectiveness of the implemented interventions.Conclusions: Using a multidisciplinary approach, we aim to assess the effectiveness of TTd, alone or in combination with ground larviciding, following a single intervention round and scrutinise the acceptability and feasibility of implementing at scale in similar hotspots of onchocerciasis infection, to accelerate onchocerciasis elimination.